Theriva Biologics Inc. (TOVX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE MKT
Market Cap: $6.61M
Last updated: Nov 17, 2026 at 11:06 AM ET
Theriva Biologics Inc. (TOVX) Earnings: Report Dates and Results
Theriva Biologics (TOVX) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Theriva Biologics reported EPS of -$0.03. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TOVX has an expected report date of Mar 10, 2027.
Earnings History
Of the 39 quarters below that had an estimate, TOVX beat 19, missed 14 and matched 6. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 582.05% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.03 | -$0.06 | -$0.06 - -$0.06 | N/A | N/A | N/A | 1 | 0 up, 1 down | Nov 12, 2026 |
| Jun 30, 2026 | -$0.07 | -$0.05 | -$0.05 - -$0.05 | -40.00% | Miss | N/A | 1 | 1 up, 0 down | Aug 11, 2026 |
| Mar 31, 2026 | -$0.05 | -$0.05 | -$0.05 - -$0.05 | 0.00% | In line | N/A | 1 | 1 up, 0 down | May 5, 2026 |
| Dec 31, 2025 | -$0.10 | -$0.37 | -$0.37 - -$0.37 | +73.46% | Beat | N/A | 1 | 1 up, 0 down | Mar 12, 2026 |
| Sep 30, 2025 | -$0.45 | -$0.38 | -$0.38 - -$0.38 | -18.42% | Miss | N/A | 1 | 1 up, 0 down | Nov 12, 2025 |
| Jun 30, 2025 | -$1.93 | -$0.47 | -$0.47 - -$0.47 | -310.64% | Miss | N/A | 1 | 0 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$1.55 | -$1.56 | -$1.56 - -$1.56 | +0.64% | Beat | N/A | 1 | 0 up, 0 down | May 14, 2025 |
| Dec 31, 2024 | -$11.49 | -$7.22 | N/A | -59.14% | Miss | N/A | N/A | 0 up, 0 down | Mar 6, 2025 |
| Sep 30, 2024 | -$6.81 | -$5.25 | -$7.25 - -$5.25 | -29.71% | Miss | N/A | 2 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$10.75 | -$4.75 | N/A | -126.32% | Miss | N/A | N/A | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$7.50 | -$8.50 | -$8.50 - -$8.50 | +11.76% | Beat | N/A | 1 | 0 up, 0 down | May 7, 2024 |
| Dec 31, 2023 | -$0.34 | -$0.41 | -$0.49 - -$0.33 | +17.07% | Beat | N/A | 2 | 0 up, 0 down | Mar 25, 2024 |
| Sep 30, 2023 | -$4.75 | -$8.50 | -$10.25 - -$8.50 | +44.12% | Beat | N/A | 2 | 0 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$8.50 | -$8.50 | -$9.50 - -$8.50 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Aug 8, 2023 |
| Mar 31, 2023 | -$7.50 | -$8.00 | -$8.00 - -$8.00 | +6.25% | Beat | N/A | 1 | 0 up, 0 down | May 11, 2023 |
| Dec 31, 2022 | -$0.33 | -$0.33 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$8.25 | -$11.25 | -$11.25 - -$8.50 | +26.67% | Beat | N/A | 2 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$7.75 | -$7.50 | N/A | -3.33% | Miss | N/A | N/A | N/A | Aug 11, 2022 |
| Mar 31, 2022 | -$0.30 | -$0.30 | N/A | 0.00% | In line | N/A | N/A | N/A | May 16, 2022 |
| Dec 31, 2021 | -$10.00 | -$5.00 | N/A | -100.00% | Miss | N/A | N/A | N/A | Mar 16, 2022 |
| Sep 30, 2021 | -$5.00 | -$5.00 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 3, 2021 |
| Jun 30, 2021 | -$5.00 | -$5.00 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 5, 2021 |
| Mar 31, 2021 | -$32.50 | -$5.00 | N/A | -550.00% | Miss | N/A | N/A | N/A | May 5, 2021 |
| Dec 31, 2020 | -$1.40 | -$0.80 | N/A | -75.00% | Miss | N/A | N/A | N/A | Mar 4, 2021 |
| Sep 30, 2020 | -$35.00 | -$40.00 | N/A | +12.50% | Beat | N/A | N/A | N/A | Nov 10, 2020 |
| Jun 30, 2020 | -$45.00 | -$35.00 | N/A | -28.57% | Miss | N/A | N/A | N/A | Aug 6, 2020 |
| Mar 31, 2020 | -$1.70 | -$2.70 | N/A | +37.04% | Beat | N/A | N/A | N/A | May 5, 2020 |
| Dec 31, 2019 | -$47.50 | -$57.50 | N/A | +17.39% | Beat | N/A | N/A | N/A | Feb 20, 2020 |
| Sep 30, 2019 | -$77.50 | -$57.50 | N/A | -34.78% | Miss | N/A | N/A | N/A | Nov 4, 2019 |
| Jun 30, 2019 | -$2.20 | -$2.30 | N/A | +4.35% | Beat | N/A | N/A | N/A | Aug 8, 2019 |
| Mar 31, 2019 | -$2.20 | -$2.30 | N/A | +4.35% | Beat | N/A | N/A | N/A | May 8, 2019 |
| Dec 31, 2018 | -$332.50 | -$48.75 | N/A | -582.05% | Miss | -4850.0% | N/A | N/A | Feb 27, 2019 |
| Sep 30, 2018 | -$232.50 | -$525.00 | N/A | +55.71% | Beat | N/A | N/A | N/A | Nov 8, 2018 |
| Jun 30, 2018 | -$262.50 | -$350.00 | N/A | +25.00% | Beat | N/A | N/A | N/A | Aug 8, 2018 |
| Mar 31, 2018 | -$175.00 | -$437.50 | N/A | +60.00% | Beat | N/A | N/A | N/A | May 8, 2018 |
| Dec 31, 2017 | $7.00 | -$16.33 | N/A | +142.87% | Beat | N/A | N/A | N/A | Feb 22, 2018 |
| Sep 30, 2017 | -$1,225.00 | -$437.50 | N/A | -180.00% | Miss | N/A | N/A | N/A | Nov 1, 2017 |
| Jun 30, 2017 | -$262.50 | -$495.83 | N/A | +47.06% | Beat | N/A | N/A | N/A | Aug 3, 2017 |
| Mar 31, 2017 | -$175.00 | -$641.67 | N/A | +72.73% | Beat | N/A | N/A | N/A | May 4, 2017 |
| Dec 31, 2016 | -$7.00 | -$26.60 | N/A | +73.68% | Beat | N/A | N/A | N/A | Mar 2, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.03, after -$36.55 the year before. It was -$2,750.38 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.03 | N/A |
| Dec 31, 2024 | -$36.55 | N/A |
| Dec 31, 2023 | -$21.09 | N/A |
| Dec 31, 2022 | -$16.63 | N/A |
| Dec 31, 2021 | -$52.50 | N/A |
| Dec 31, 2020 | -$83.10 | N/A |
| Dec 31, 2019 | -$129.40 | N/A |
| Dec 31, 2018 | -$1,002.50 | N/A |
| Dec 31, 2017 | -$1,655.50 | N/A |
| Dec 31, 2016 | -$2,750.38 | N/A |
Frequently Asked Questions About TOVX
When is Theriva Biologics's next earnings date?
Theriva Biologics's next earnings report is expected for Mar 10, 2027.
What EPS do analysts expect from TOVX next quarter?
The consensus EPS estimate for Theriva Biologics for the quarter ending Dec 31, 2026 is -$0.06 from 3 analysts, with estimates from -$0.06 to -$0.06.
How often does TOVX beat earnings estimates?
Theriva Biologics beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -47.98%.
TOVX pages: Overview, Earnings, Forecast, Financials, Competitors